✦ LIBER ✦

Prognostic value of Cyclin D2 mRNA expression in newly diagnosed multiple myeloma treated with high-dose chemotherapy and tandem autologous stem cell transplantations

✍ Scribed by Hanamura, I; Huang, Y; Zhan, F; Barlogie, B; Shaughnessy, J

Book ID: 110056771
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 200 KB
Volume: 20
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2404253

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiac toxicity of high-dose cyclophosp

Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation

✍ Samo Zver; Vesna Zadnik; Peter Černelč; Mirta Koželj 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 298 KB

Cyclophosphamide plus dexamethasone is a

Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma : Results of a randomized comparison with vincristine, doxorubicin, and dexamethasone

✍ Ulf-Henrik Mellqvist; Stig Lenhoff; Hans E. Johnsen; Martin Hjorth; Erik Holmber 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

## Abstract ## BACKGROUND Today, intensive therapy that includes high‐dose melphalan with autologous stem cell transplantation (ASCT) is considered standard therapy in younger patients with newly diagnosed myeloma. When the current trial was initiated, combined vincristine, doxorubicin, and dexame